Ulla Grove Krogsgaard Thomsen holds a M.Sc. in Pharmaceutical Sciences from 1992 and a Ph.D. in Structural and Analytical chemistry from 1996, both obtained at University of Copenhagen.
Dr. Thomsen joined Novo Nordisk Pharmatech A/S in 2021 as the CEO. Since 2019 she has been a member of the Bord of Directors. Dr. Thomsen joined Novo Nordisk A/S in 1997 where she initially headed up various scientific and leadership positions within Protein Engineering Research. For the last 12 years Dr. Thomsen has headed up Biopharmaceuticals API production in Product Supply.
Dr. Thomsen is a Danish National, born in 1968.